Extracorporeal Membrane Oxygenation Complication Clinical Trial
Official title:
A Randomised Controlled Trial of Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation (ECMO-Rehab)
Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for months or years. This registry-embedded randomised trial aims to determine if early rehabilitation commenced within 72 hours of ECMO is feasible and improves muscle strength and functional status in patients compared to standard practice in a randomised controlled trial of 100 ICU patients. The effect of the intervention on mortality, health status, and function at 180 days will be evaluated, as well as cost-effectiveness. ECMO-Rehab trial is a registry embedded trial and will be utilising EXCEL data.
The trial is a 100-patient, multicentre, randomised, controlled, parallel-group, two-sided superiority trial that will randomly allocate eligible patients to early rehabilitation or standard care in a 1:1 ratio to determine if early rehabilitation of critically ill patients receiving ECMO reduces disability when compared with standard care. ECMO-Rehab trial is a registry embedded trial and will be utilising EXCEL data. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05486559 -
The ECMO-Free Trial
|
N/A | |
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Not yet recruiting |
NCT05306392 -
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
|
N/A | |
| Terminated |
NCT02280460 -
ECMO: Optimization of Its Use
|
||
| Completed |
NCT02271126 -
TEG Anticoagulation Monitoring During ECMO
|
Phase 1 | |
| Recruiting |
NCT05444764 -
PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
|
||
| Completed |
NCT03659513 -
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
|
||
| Not yet recruiting |
NCT06338345 -
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
|
N/A | |
| Completed |
NCT05948332 -
Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
|
||
| Recruiting |
NCT04273607 -
Anticoagulation-free VV ECMO for Acute Respiratory Failure
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04956497 -
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
|
||
| Completed |
NCT04052230 -
Evolution of Diaphragm Thickness Under Veno-arterial ECMO
|
||
| Terminated |
NCT04524585 -
Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
|
N/A | |
| Completed |
NCT04620005 -
Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units.
|
||
| Recruiting |
NCT05721105 -
Evaluation of Long-term Quality of Life in Children Supported With ExtraCorporeal Membrane Oxygenation (ECMO)
|
||
| Recruiting |
NCT06095518 -
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
|
||
| Recruiting |
NCT03965208 -
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
|
Phase 4 | |
| Not yet recruiting |
NCT05814094 -
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
|
N/A | |
| Not yet recruiting |
NCT06319677 -
PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
|
||
| Completed |
NCT05338593 -
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
|